82
Views
3
CrossRef citations to date
0
Altmetric
Case Report

First case of Abiotophia defectiva infectious endocarditis treated with a combination of amoxicillin and daptomycin

ORCID Icon, &
Pages 323-325 | Received 12 Aug 2019, Accepted 19 Feb 2020, Published online: 12 Mar 2020
 

Abstract

Abiotophia defectiva (A. defectiva) infectious endocarditis (IE) is a serious disease that usually requires lengthy treatment with a combination of amoxicillin and gentamicin. Since severe nephrotoxicity can be associated with prolonged administration of gentamicin, the alternative use of daptomycin in combination with amoxicillin can be considered. We present the case of a 51-year-old man that presented an A. defectiva endocarditis on an aortic bicuspidy. Diagnosis of cirrhosis was made simultaneously, and therefore gentamicin was counter-indicated. A combination of amoxicillin 12 g per day and daptomycin 700 mg (10 mg/kg) was administrated, with resolution of clinical, biological and echographic abnormalities, and no relapse after 1 year. In our experience, amoxicillin with daptomycin could be an alternative in case of A. defectiva IE with counter-indication to aminoglycosides.

Acknowledgments

Authors are deeply indebted to Juliusz Chroboczek for his help with proof reading.

Conflict of interest

No financial support was received, and none of the authors has a conflict of interest concerning this report.

Notes on contributors

Tomasz Chroboczek (MD) is an infectious diseases specialist. He works in the infectious diseases department of the Centre HospitalierAlpes Léman, in Contamine sur Arves, France.Julie Le Scanff (MD) is an internal medicine specialist. She works in the internal medicine department of the Hôpital Nord Ouest, in Villefranche sur Saône, France.Gary David (MD) is an infectious diseases specialist. He currently heads the infectious diseases department of the Hôpital Nord Ouest, in Villefranche sur Saône, France.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.